Alternative Data for Revvity
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 130 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 158,000 | Sign up | Sign up | Sign up |
| Employee Rating | 58 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 23 | Sign up | Sign up | Sign up |
| Facebook Followers | 145,879 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,786 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 782 | Sign up | Sign up | Sign up |
| X Followers | 43,360 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 697 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 33 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,438 | Sign up | Sign up | Sign up |
About Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families.
| Price | $114.61 |
| Target Price | Sign up |
| Volume | 897,390 |
| Market Cap | $13.5B |
| Year Range | $82.39 - $117.75 |
| Dividend Yield | 0.24% |
| PE Ratio | 60.17 |
| Analyst Rating | 62% buy |
| Earnings Date | February 2 '26 |
| Industry | Health Care Services |
In the news
 |
Revvity Board Declares Quarterly DividendJanuary 26 - Yahoo |
|
Revvity (RVTY) Earnings Expected to Grow: Should You Buy?January 25 - Yahoo |
|
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?January 23 - Yahoo |
|
Here's Why You Should Retain Revvity Stock in Your Portfolio for NowJanuary 20 - Yahoo |
|
The Bull Case For Revvity (RVTY) Could Change Following Upbeat 2025 Guidance And New Lilly AI AllianceJanuary 14 - Yahoo |
 |
Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 699M | 324M | 375M | 47M | 181M | 0.400 |
| Q2 '25 | 720M | 328M | 393M | 55M | 194M | 1.180 |
| Q1 '25 | 665M | 338M | 327M | 41M | 173M | 1.010 |
| Q4 '24 | 729M | 370M | 360M | 95M | 222M | 1.420 |
| Q3 '24 | 684M | 299M | 385M | 94M | 232M | 1.280 |
Insider Transactions View All
| MICHAS ALEXIS P filed to sell 7,270 shares at $89. August 28 '25 |
| McMurry-Heath Michelle filed to sell 4,833 shares at $92.2. May 30 '25 |
| McMurry-Heath Michelle filed to sell 3,021 shares at $119.5. February 7 '25 |
| Goldberg Joel S filed to sell 48,070 shares at $124.5. January 31 '25 |
| Goldberg Joel S filed to sell 45,360 shares at $126. January 31 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Oct 13, 25 | Buy | $1K - $15K |
| Gilbert Cisneros |
Sep 12, 25 | Buy | $1K - $15K |
| Gilbert Cisneros |
Aug 15, 25 | Buy | $1K - $15K |
Read more about Revvity (RVTY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Revvity
The Market Cap of Revvity is $13.5B.
As of today, Revvity's PE (Price to Earnings) ratio is 60.17.
Revvity will report its next earnings on February 2 '26.
Currently, the price of one share of Revvity stock is $114.61.
The RVTY stock price chart above provides a comprehensive visual representation of Revvity's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Revvity shares. Our platform offers an up-to-date RVTY stock price chart, along with technical data analysis and alternative data insights.
Yes, Revvity (RVTY) offers dividends to its shareholders, with a dividend yield of 0.24%. This dividend yield represents Revvity's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Revvity in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Revvity are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
